TK-642 Phase 2 Study
Phase 2
- Conditions
- ncontrollable cancer pain
- Registration Number
- JPRN-jRCT2080221268
- Lead Sponsor
- TEIKOKU SEIYAKU CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1)Japanese cancer patients who can be hospitalized for clinical trial
2)Patients who are 20-74 years old at the time of informed consent
3)Patients who have been received cancer pain therapy with opioid for over 1 week
etc.
Exclusion Criteria
1)Patients who have any complications or history of cardiac conduction disturbance
2)Patients who have any complications or history of abnormality of respiratory function
3)Patients with any organic encephalopathies
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method